Correlation Between ZyVersa Therapeutics and Kura Oncology
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Kura Oncology, you can compare the effects of market volatilities on ZyVersa Therapeutics and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Kura Oncology.
Diversification Opportunities for ZyVersa Therapeutics and Kura Oncology
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ZyVersa and Kura is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Kura Oncology go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Kura Oncology
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Kura Oncology. In addition to that, ZyVersa Therapeutics is 1.9 times more volatile than Kura Oncology. It trades about -0.08 of its total potential returns per unit of risk. Kura Oncology is currently generating about 0.03 per unit of volatility. If you would invest 996.00 in Kura Oncology on August 27, 2024 and sell it today you would earn a total of 84.00 from holding Kura Oncology or generate 8.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Kura Oncology
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Kura Oncology |
ZyVersa Therapeutics and Kura Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Kura Oncology
The main advantage of trading using opposite ZyVersa Therapeutics and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Kura Oncology vs. Protagonist Therapeutics | Kura Oncology vs. Merus BV | Kura Oncology vs. Replimune Group | Kura Oncology vs. Kalvista Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |